NM_000535.7:c.751G>A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4BP6
The NM_000535.7(PMS2):c.751G>A(p.Val251Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000592 in 1,605,898 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000535.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000334 AC: 5AN: 149630Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 250208Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135244
GnomAD4 exome AF: 0.0000618 AC: 90AN: 1456268Hom.: 0 Cov.: 30 AF XY: 0.0000648 AC XY: 47AN XY: 724950
GnomAD4 genome AF: 0.0000334 AC: 5AN: 149630Hom.: 0 Cov.: 29 AF XY: 0.0000138 AC XY: 1AN XY: 72636
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:2Benign:1
This missense variant replaces valine with methionine at codon 251 of the PMS2 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with early onset colorectal cancer (PMID: 31428572). This individual also carried a pathogenic variant in the MUTYH gene that could explain the observed phenotype. This variant has been identified in 6/281164 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
- -
not specified Uncertain:2
Variant summary: PMS2 c.751G>A (p.Val251Met) results in a conservative amino acid change located in the Ribosomal protein S5 domain 2-like domain (IPR020568) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 250208 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.751G>A has been reported in the literature in individuals affected with early onset colorectal cancer or an unspecified hereditary cancer, both without evidence of causality (e.g. Zhunussova_2019, Sjursen_2024). These reports do not provide unequivocal conclusions about association of the variant with Hereditary Nonpolyposis Colorectal Cancer. A co-occurrence with another pathogenic variant was identified through internal testing (CHEK2 c.1100delC, p.Thr367MetfsX15), providing supporting evidence for a benign role. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 39334433, 31428572). ClinVar contains an entry for this variant (Variation ID: 182801). Based on the evidence outlined above, the variant was classified as uncertain significance. -
- -
Lynch syndrome Uncertain:2
This missense variant replaces valine with methionine at codon 251 of the PMS2 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with early onset colorectal cancer (PMID: 31428572). This individual also carried a pathogenic variant in the MUTYH gene that could explain the observed phenotype. This variant has been identified in 6/281164 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
- -
not provided Uncertain:2
The frequency of this variant in the general population, 0.000031 (4/128504 chromosomes, http://gnomad.broadinstitute.org), is uninformative in assessment of its pathogenicity. In the published literature, the variant has been reported in an individual with colorectal cancer (PMID: 31428572 (2019)). Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded conflicting predictions that this variant is benign or damaging. Based on the available information, we are unable to determine the clinical significance of this variant. -
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 35449176, 31428572, 11574484) -
Lynch syndrome 4 Uncertain:1
- -
PMS2-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Hereditary nonpolyposis colorectal neoplasms Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at